Fact CheckerSign in

NCT07279922Not yet recruiting

What is the Role of Triglyceride-glucose Index as a Predictive Marker for Insulin Resistance in Pre Diabetic Chronic Kidney Disease Patients?

The Role of Triglyceride-glucose Index as a Predictive Marker for Insulin Resistance in Pre Diabetic Chronic Kidney Disease Patients.

Source: ClinicalTrials.gov · Last updated 12 Dec 2025

Brief summary (registry, in English)

The aim of this study is to evaluate the role of the triglyceride-glucose (TyG) index as a predictive marker for insulin resistance in pre-diabetic patients with chronic kidney disease (CKD), and to investigate its potential utility as a simple, non-invasive alternative to traditional insulin resistance assessment methods.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
1 Dec 2025
Start date
1 Jan 2026
Primary completion date
1 Jan 2028
Lead sponsor
Assiut University
NCT number
NCT07279922

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 1 Jan 2026 to the primary completion date, 1 Jan 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • Known type 1 or type 2 diabetes mellitus
    • Acute kidney injury
    • Use of steroids or medications that affect glucose and lipid metabolism
    • Pregnancy
    • Active infections
    • Malignancy

Who the study is looking for

  • Adults aged ≥18 years
    • Patients with medical history free from renal dysfunction
    • Patients with renal dysfunction (CKD stages 2\_5 based on KDIGO guidelines)
    • No previous diagnosis of diabetes mellitus
    • Provided informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.